Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Exp Eye Res. 2008 Nov 13;88(3):467–478. doi: 10.1016/j.exer.2008.10.023

Fig. 5.

Fig. 5

Acute release of vIL-10 and β-hexosaminidase from LGAC. Rabbit LGACs were cultured and transduced with AdvIL-10 as described in the legend for Fig. 3. After treatment with or without 100 μM CCH at time intervals from 0 to 30 min, aliquots of the medium were collected and processed for measurement of vIL-10 (A) and β-hexosaminidase (B) release using ELISA and biochemical assays, respectively. vIL-10 and β-hexosaminidase release are plotted as % of total, with total defined as the maximal release elicited by 100 μM CCH at 30 min. n = 5 and *, significant at p ≤ 0.05, AdvIL-10 (+)CCH versus AdvIL-10 (−)CCH (A) and AdvIL-10 (+)CCH versus Control (+)CCH (B). Error bars represent s.e.m.